‘On-And Off-Ramps’ For Cancer Accelerated Approvals: FDA Suggests Earlier Randomized Trials

Leaders of FDA’s oncology center say sponsors could initiate a single randomized trial prior to receiving accelerated approval or conduct a single-group AA study concurrently with a randomized trial. FDA and sponsor could agree in advance on criteria for approval and withdrawal.

FDA officials make recommendations for navigating on-ramp and off-ramp of accelerated approval pathway • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

More from Review Pathways

More from Pathways & Standards